Is MDxHealth Stock a Good Investment?

MDxHealth Investment Advice

MDXH

To provide specific investment advice or recommendations on MDxHealth SA ADR stock, we recommend investors consider the following general factors when evaluating MDxHealth SA ADR. This will help you to make an informed decision on whether to include MDxHealth in one of your diversified portfolios:

Examine MDxHealth's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research MDxHealth's leadership team and their track record. Good management can help MDxHealth navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Biotechnology space and any emerging trends that could impact MDxHealth's business and its evolving consumer preferences.
Compare MDxHealth's performance and market position to its competitors. Analyze how MDxHealth is positioned in terms of product offerings, innovation, and market share.
Check if MDxHealth pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about MDxHealth's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in MDxHealth SA ADR stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if MDxHealth SA ADR is a good investment.

Sell

Buy

Strong Sell

We provide investment recommendation to complement the last-minute expert consensus on MDxHealth SA ADR. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. To make sure MDxHealth SA ADR is not overpriced, please verify all MDxHealth SA ADR fundamentals, including its book value per share, and the relationship between the cash and equivalents and number of employees . Please also check out MDxHealth number of shares shorted to check your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Market Performance	Very Weak	Details
Volatility	Very risky	Details
Hype Condition	Stale	Details
Current Valuation	Fairly Valued	Details
Odds Of Distress	Low	Details
Economic Sensitivity	Slowly supersedes the market	Details
Investor Sentiment	Impartial	Details
Analyst Consensus	Buy	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Unavailable	Details

Examine MDxHealth Stock

Researching MDxHealth's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 12.0% of the company outstanding shares are owned by corporate insiders. The book value of MDxHealth was now reported as 0.61. The company recorded a loss per share of 1.53. MDxHealth SA ADR had not issued any dividends in recent years. The entity had 1:10 split on the 14th of November 2023.

To determine if MDxHealth is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding MDxHealth's research are outlined below:

	MDxHealth SA ADR generated a negative expected return over the last 90 days
	MDxHealth SA ADR may become a speculative penny stock
	MDxHealth SA ADR has high historical volatility and very poor performance
	The company reported the previous year's revenue of 70.19 M. Net Loss for the year was (43.1 M) with profit before overhead, payroll, taxes, and interest of 19.22 M.
	MDxHealth SA ADR currently holds about 40.02 M in cash with (21.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.57, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
	Roughly 12.0% of the company outstanding shares are owned by corporate insiders
	Latest headline from gurufocus.com: AWM Investment Companys Strategic Acquisition of MDxHealth SA Shares

MDxHealth Quarterly Good Will

35.93 Million

MDxHealth uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in MDxHealth SA ADR. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to MDxHealth's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	13th of March 2024 Upcoming Quarterly Report	View
	20th of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	13th of March 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Earnings surprises can significantly impact MDxHealth's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises MDxHealth's investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2023-08-23	2023-06-30	-0.22	-0.3	-0.08	36
2023-05-15	2023-03-31	-0.4132	-0.5	-0.0868	21
2022-08-26	2022-06-30	-0.6	-0.7	-0.1	16
2024-11-06	2024-09-30	-0.27	-0.4	-0.13	48
2024-08-21	2024-06-30	-0.26	-0.42	-0.16	61
2023-11-08	2023-09-30	-0.19	-0.4	-0.21	110
2024-03-06	2023-12-31	-0.11	-0.39	-0.28	254
2022-03-02	2021-12-31	-0.47	-0.88	-0.41	87

Know MDxHealth's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as MDxHealth is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MDxHealth SA ADR backward and forwards among themselves. MDxHealth's institutional investor refers to the entity that pools money to purchase MDxHealth's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

			Shares
	Rhumbline Advisers	2024-06-30	72.0

Note, although MDxHealth's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

MDxHealth's market capitalization trends

The company currently falls under 'Micro-Cap' category with a current market capitalization of 84.64 M.

Market Cap

118.45 Million

MDxHealth's profitablity analysis

	Last Reported	Projected for Next Year
Return On Tangible Assets	(0.88)	(0.93)
Return On Capital Employed	(0.25)	(0.26)
Return On Assets	(0.33)	(0.35)
Return On Equity	(5.98)	(5.68)

The company has Profit Margin (PM) of (0.5) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.26) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.26.

Determining MDxHealth's profitability involves analyzing its financial statements and using various financial metrics to determine if MDxHealth is a good buy. For example, gross profit margin measures MDxHealth's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of MDxHealth's profitability and make more informed investment decisions.

Evaluate MDxHealth's management efficiency

MDxHealth SA ADR has return on total asset (ROA) of (0.1102) % which means that it has lost $0.1102 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.4082) %, meaning that it created substantial loss on money invested by shareholders. MDxHealth's management efficiency ratios could be used to measure how well MDxHealth manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.93. The current Return On Capital Employed is estimated to decrease to -0.26. As of now, MDxHealth's Intangible Assets are increasing as compared to previous years. The MDxHealth's current Intangibles To Total Assets is estimated to increase to 0.65, while Other Current Assets are projected to decrease to under 1.5 M.

	Last Reported	Projected for Next Year
Book Value Per Share	0.28	0.26
Tangible Book Value Per Share	(2.82)	(2.68)
Enterprise Value Over EBITDA	(3.97)	(3.77)
Price Book Value Ratio	14.16	14.87
Enterprise Value Multiple	(3.97)	(3.77)
Price Fair Value	14.16	14.87
Enterprise Value	121 M	127 M

The management strategies employed by MDxHealth's are designed to enhance shareholder value and ensure long-term growth. We assess the effectiveness of these strategies in our stock analysis.

Beta

-394 K

Basic technical analysis of MDxHealth Stock

As of the 22nd of November, MDxHealth secures the Risk Adjusted Performance of (0.17), mean deviation of 2.45, and Standard Deviation of 3.89. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MDxHealth SA ADR, as well as the relationship between them.

MDxHealth's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific MDxHealth insiders, such as employees or executives, is commonly permitted as long as it does not rely on MDxHealth's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases MDxHealth insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Mvm Partners Llc over a year ago

Purchase by Mvm Partners Llc of 1000000 shares of MDxHealth

MDxHealth's Outstanding Corporate Bonds

MDxHealth issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. MDxHealth SA ADR uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most MDxHealth bonds can be classified according to their maturity, which is the date when MDxHealth SA ADR has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	Boeing Co 2196 Corp Bond US097023DG73	View
	HSBC Holdings PLC Corp Bond US404280DR76	View
	MGM Resorts International Corp Bond US552953CD18	View
	MEAD JOHNSON NUTRITION Corp Bond US582839AH96	View
	MEAD JOHNSON NUTRITION Corp Bond US582839AG14	View
	AerCap Global Aviation Corp Bond US00773HAA59	View

View All MDxHealth Corporate Bonds

Understand MDxHealth's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing MDxHealth's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	(0.17)
	Market Risk Adjusted Performance	(1.32)
	Mean Deviation	2.45
	Coefficient Of Variation	(433.53)
	Standard Deviation	3.89
	Variance	15.11
	Information Ratio	(0.26)
	Jensen Alpha	(0.97)
	Total Risk Alpha	(1.41)
	Treynor Ratio	(1.33)
	Maximum Drawdown	27.04
	Value At Risk	(6.29)
	Potential Upside	3.5
	Skewness	(2.58)
	Kurtosis	11.53

	Risk Adjusted Performance	(0.17)
	Market Risk Adjusted Performance	(1.32)
	Mean Deviation	2.45
	Coefficient Of Variation	(433.53)
	Standard Deviation	3.89
	Variance	15.11
	Information Ratio	(0.26)
	Jensen Alpha	(0.97)
	Total Risk Alpha	(1.41)
	Treynor Ratio	(1.33)
	Maximum Drawdown	27.04
	Value At Risk	(6.29)
	Potential Upside	3.5
	Skewness	(2.58)
	Kurtosis	11.53

Consider MDxHealth's intraday indicators

MDxHealth intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of MDxHealth stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	22376.4
	Daily Balance Of Power	0.85
	Rate Of Daily Change	1.1
	Day Median Price	1.79
	Day Typical Price	1.82
	Price Action Indicator	0.17
	Period Momentum Indicator	0.17

MDxHealth time-series forecasting models is one of many MDxHealth's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MDxHealth's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

MDxHealth Stock media impact

Far too much social signal, news, headlines, and media speculation about MDxHealth that are available to investors today. That information is available publicly through MDxHealth media outlets and privately through word of mouth or via MDxHealth internal channels. However, regardless of the origin, that massive amount of MDxHealth data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of MDxHealth news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of MDxHealth relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to MDxHealth's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive MDxHealth alpha.

MDxHealth Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards MDxHealth can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

MDxHealth Corporate Management

Wim Criekinge	Chief Officer	Profile
Joseph Sollee	Executive Counsel	Profile
Ron CPA	Chief Officer	Profile
John Bellano	Chief Officer	Profile
Jason Poole	Chief Officer	Profile
Miriam Reyes	Executive Operations	Profile
Paul Marr	Ex America	Profile

When determining whether MDxHealth SA ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MDxHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mdxhealth Sa Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mdxhealth Sa Adr Stock: